Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
08/30/2011 | US8008271 Methods and compositions for treating gain-of-function disorders using RNA interference |
08/30/2011 | US8008270 Antiviral oligonucleotides targeting viral families |
08/30/2011 | US8008269 Antiviral oligonucleotides |
08/30/2011 | US8008268 Vaccines against vesicular stomatitis |
08/30/2011 | US8008267 Modified dinucleotides for reduce or improve immunostimulatory; genetic vaccines; cancer vaccines |
08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
08/30/2011 | US8008265 Vaccines, immunotherapeutics and methods for using the same |
08/30/2011 | US8008257 ANF fusion proteins |
08/30/2011 | US8008078 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
08/30/2011 | US8008076 Method of producing a nucleic acid encoding an antibody |
08/30/2011 | US8008073 Anti-Mpl antibodies |
08/30/2011 | US8008071 Vector comprising first polynucleotide encoding glucose responsive mRNA instability element, second polynucleotide encoding reporter polypeptide and promoter sequence; fluorescence based high throughput screening |
08/30/2011 | US8008056 Variant Hypocrea jecorina CBH2 cellulases |
08/30/2011 | US8008053 Allosteric control of proteins by manipulating mechanical tension |
08/30/2011 | US8008052 Process for producing glycolic acid from formaldehyde and hydrogen cyanide |
08/30/2011 | US8008049 DNA coding for polypeptide participating in biosynthesis of pladienolide |
08/30/2011 | US8008048 L-cysteine-producing bacterium and a method for producing L-cysteine |
08/30/2011 | US8008047 L-amino acid producing bacterium which has enhanced expression of at least one of the nhaA gene, the nhaB gene, the nhaR gene, the chaA gene, the mdfA gene and a method of producing L-amino acid |
08/30/2011 | US8008041 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells |
08/30/2011 | US8008017 Compositions and methods for detecting the presence of cryptosporidium organisms in a test sample |
08/30/2011 | US8008016 Vectors and methods for high throughput co-expressions |
08/30/2011 | US8008015 Genetic markers of the risk of developing restenosis |
08/30/2011 | US8008010 Chimeric oligonucleotides for ligation-enhanced nucleic acid detection, methods and compositions therefor |
08/30/2011 | US8008005 Method for the synthesis of DNA sequences |
08/30/2011 | US8008003 Gene expression profiling of EGFR positive cancer |
08/30/2011 | US8008002 Nucleic acid sequencing |
08/30/2011 | US8007813 CD95-Fc fusion proteins |
08/30/2011 | US8007804 Complement receptor 2 targeted complement modulators |
08/30/2011 | US8007779 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
08/30/2011 | CA2498651C Nucleoside triphosphate diphosphohydrolase and uses thereof |
08/30/2011 | CA2490413C Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
08/25/2011 | WO2011103532A1 Primer sequences for amplification of sea otter genes, and methods of use thereof |
08/25/2011 | WO2011103468A2 Phosphoramidites for synthetic rna in the reverse direction |
08/25/2011 | WO2011103453A2 Vaccines for use in the prophylaxis and treatment of influenza virus disease |
08/25/2011 | WO2011103407A1 Primers and methods for nucleic acid amplification |
08/25/2011 | WO2011103248A2 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE |
08/25/2011 | WO2011103247A2 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
08/25/2011 | WO2011103215A1 Embedded chimeric peptide nucleic acids and use thereof |
08/25/2011 | WO2011102913A2 Wicking-based reagent-solution draining in an automated system |
08/25/2011 | WO2011102414A1 Oligonucleotide derivative |
08/25/2011 | WO2011064668A3 Plants that reproduce via unreduced gametes |
08/25/2011 | US20110209254 Qtl controlling sclerotinia stem rot resistance in soybean |
08/25/2011 | US20110209250 Methods and compositions for plant improvement |
08/25/2011 | US20110209248 Novel sugar transporters |
08/25/2011 | US20110209246 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
08/25/2011 | US20110209245 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof |
08/25/2011 | US20110209244 Method for production of plant imparted with stress tolerance and use thereof |
08/25/2011 | US20110209242 Green Tissue-Preferred Promoter from Maize |
08/25/2011 | US20110209241 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
08/25/2011 | US20110209232 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
08/25/2011 | US20110209230 Human Monoclonal Antibodies To Programmed Death Ligand 1 (PD-L1) |
08/25/2011 | US20110209229 Gene of porcine beta casein, a promoter of the same and the use thereof |
08/25/2011 | US20110208673 Antibodies to lymphotoxin-alpha |
08/25/2011 | US20110207920 5-bromo-2'-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same |
08/25/2011 | US20110207912 Fgf-19 nucleic acids |
08/25/2011 | US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage |
08/25/2011 | US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response |
08/25/2011 | US20110207800 HIV-Dependent expression constructs and uses therefore |
08/25/2011 | US20110207775 Agent that modulates physiological condition of pests, involved in insect vesicle-fusing atpase activity |
08/25/2011 | US20110207679 Methods of treatment using il-16 antagonist peptides |
08/25/2011 | US20110207669 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation |
08/25/2011 | US20110207668 Binding proteins inhibiting the vegf-a receptor interaction |
08/25/2011 | US20110207667 Efficient expression of truncated human rnaset2 in e. coli |
08/25/2011 | US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof |
08/25/2011 | US20110207659 Oligosaccharide compositions and use thereof in the treatment of infection |
08/25/2011 | US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS |
08/25/2011 | US20110207631 METHOD FOR PRODUCTION OF cDNA LIBRARY HAVING REDUCED CONTENT OF cDNA CLONE DERIVED FROM HIGHLY EXPRESSED GENE |
08/25/2011 | US20110207630 Method for testing and quality controlling of nucleic acids on a support |
08/25/2011 | US20110207623 Methods for detection and quantification of analytes in complex mixtures |
08/25/2011 | US20110207622 Salivary biomarkers for lung cancer detection |
08/25/2011 | US20110207608 Transcriptional and post-transcription regulation of transcription factor for drought resistance |
08/25/2011 | US20110207221 Targeted genomic modification with partially single-stranded donor molecules |
08/25/2011 | US20110207212 T1r taste receptors and genes encoding same |
08/25/2011 | US20110207198 Compositions and methods for inhibiting mmset |
08/25/2011 | US20110207197 Method to inhibit ribonuclease dicer, ribonuclease dicer inhibitor, and use of rna aptamers as ribonuclease dicer inhibitors |
08/25/2011 | US20110207186 Isoforms of Pig Liver Esterase |
08/25/2011 | US20110207132 Probes and methods for detecting analytes |
08/25/2011 | US20110207125 Method for labelling a product using a plurality of polynucleotides, method for identifying the labelling and labelled product |
08/25/2011 | US20110207124 Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism |
08/25/2011 | US20110207122 Method for determination of progression risk of glaucoma |
08/25/2011 | US20110207120 Wnt1 as a renal damage biomarker |
08/25/2011 | US20110207118 Dna template tailoring using pna and modified nucleotides |
08/25/2011 | US20110207116 Spatio-temporal control of protein interactions using phytochromes |
08/25/2011 | US20110206736 Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same |
08/25/2011 | US20110206724 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
08/25/2011 | US20110206719 Immunostimulatory oligoribonucleotides |
08/25/2011 | US20110206718 Anti-fmd vaccine composition and preparation and use thereof |
08/25/2011 | US20110206714 Malaria vaccine compositions and constituents which elicit cell mediated immunity |
08/25/2011 | US20110206713 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
08/25/2011 | US20110206712 Tuberculosis rv2386c protein, compositions and uses thereof |
08/25/2011 | US20110206702 Compositions and methods for the diagnosis and treatment of tumor |
08/25/2011 | US20110206700 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
08/25/2011 | US20110206698 Antagonist anti-il-7 receptor antibodies and methods |
08/25/2011 | US20110206693 Lysine riboswitch and compositions and uses thereof |
08/25/2011 | US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
08/25/2011 | US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
08/25/2011 | US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization |
08/25/2011 | US20110206675 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
08/25/2011 | US20110206663 Anti-Interferon-Alpha Antibodies |
08/25/2011 | US20110206660 Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same |